Yaron Conforti

Numinus Wellness Inc. (TSX:NUMI)(OTCQX: NUMIF) and Novamind Inc. (CSE:NM)(OTCQB: NVMDF)(FSE:HN2) have entered into a definitive arrangement agreement pursuant to which Numinus will acquire all of the issued and outstanding common shares of Novamind in an all-share transaction, by way of a court-...

Novamind Inc. (OTCQB: NVMDF) has announced that it will offer a model of psychedelic-assisted group therapy. Under the name Groups by Novamind, the therapy model will offer psychedelic integration and in-person group psychedelic-assisted psychotherapy for four to ten individuals delivered as drop-...

Psychedelics-focused mental health company Novamind Inc. (CSE:NM) (OTCQB: NVMDF) (FSE: HN2) reported its financial results for the three and six months ended December 31, 2021. “We’re pleased to report record high revenue this quarter driven by continued revenue growth from existing and...

Novamind Inc. (OTCPink: NVMDF), a company specializing in mental health and psychedelics treatment, announced on Tuesday it intends to open four new psychiatry clinics in Utah. The clinics, operating under the Cedar Psychiatry brand, are expected to increase the company’s patient volume by...

In 2020, psychedelics took the world by storm. Over two dozen companies in the sector became publicly listed.  The industry grew closer to federal legalization of the first psychedelic compounds for therapeutic use. With scientific, regulatory and corporate developments becoming...

NeonMind Goes Public Psychedelics biotech company NeonMind debuted on the Canadian Securities Exchange (CSE) Monday under the symbol ‘NEON.’ NeonMind CEO Penny White discussed the highly anticipated — oversubscribed — initial public offering (IPO) on the Jan. 7 edition...

Novamind became the latest psychedelics company to go public through a reverse take-over with Hinterland Metals Inc. The company debuted in the Canadian Securities Exchange on Tuesday under the symbol "NM." In late November, Novamind closed a private placement for CA$10 million ($7.8...

Novamind Raises CA$10M, Heads Towards CSE Listing Toronto-based psychedelics company Novamind Ventures announced the closing of a private placement for CA$10 million ($7.6 million). Last week, the company confirmed that it successfully inked a definitive amalgamation agreement with Hinterland...